Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Relation
United Kingdom
- London
- 15/03/2024
- Seed
- $35,000,000
We are an end-to-end biotech developing transformational medicines, with technology at our core.
Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure.
Medicines born from high-resolution biology, machine learning and clinical insights.
Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
- Industry Biotechnology Research
- Website https://www.relationrx.com/
- LinkedIn https://www.linkedin.com/company/relation-therapeutics/
Related People
David RoblinFounder
United Kingdom -
London, England
David Roblin is a distinguished scientist, physician, drug developer, and life-sciences executive. He has been involved in Relation since its founding, while engaged as CEO of Juvenescence Therapeutics, an early investor in Relation. Before joining Relation, he enjoyed a career in biotech, pharma and academia developing many important medicines in research, development, and commercial roles. Major roles include COO and Chair of Scientific Translation at the Francis Crick Institute and Head of European R&D for Pfizer. He is currently also a Non-Executive Director of Sosei (SOLTF), Non-Executive Chair of Centauri Therapeutics and remains Chair of Scientific Translation at the Crick.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
KeySavvy | $4,250,000 | (Nov 22, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)